Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.24.0.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Allowance for other receivables $ 4,600 $ 0
Allowance for value added tax and other receivables $ 0 $ 8,400
Preferred stock, par value (in dollars per share) $ 25 $ 25
Preferred stock, shares authorized (in shares) 500,000 500,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.1 $ 0.1
Common stock, shares authorized (in shares) 160,000,000 160,000,000
Common stock, shares issued (in shares) 121,397,553 119,482,680
Common stock, shares outstanding (in shares) 104,346,233 107,852,857
Treasury stock, shares (in shares) 17,051,320 11,629,823
Trade Accounts Receivable [Member]    
Allowances for credit losses $ 500 $ 0
Accounts With Joint Venture Owners [Member]    
Allowances for credit losses $ 800 $ 300